Polymorphisms of the KCNQ1 gene are associated with the therapeutic responses of sulfonylureas in Chinese patients with type 2 diabetes

Qing Li(Army Medical University), Weiping Jia(NovaBay Pharmaceuticals (United States)), Cheng Hu(Shanghai Jiao Tong University), Tingting Tang(Chongqing Academy of Forestry), Jun Yin(Chongqing University), Rong Zhang(Huazhong Agricultural University), Feng Jiang(Nanjing Drum Tower Hospital), Xiang Cheng(Union Hospital), Miao Chen(Shanghai Jiao Tong University), Yuqian Bao(Shanghai Jiao Tong University)
Acta Pharmacologica Sinica
October 3, 2016
10.1038/aps.2016.103
Cited by 25

Related Papers

Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
|Diabetes Care|2019|3.8k
Prevalence of Diabetes among Men and Women in China
|New England Journal of Medicine|2010|3.1k
International Consensus on Use of Continuous Glucose Monitoring
|Diabetes Care|2017|2k
Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility
|Nature Genetics|2014|1.1k
Low-dose metformin targets the lysosomal AMPK pathway through PEN2
|Nature|2022|628